Wang Bing, Sun Ming-Yu, Long Ai-Hua, Cao Hong-Yan, Ren Shuang, Bian Yan-Qin, Lu Xiong, Gu Hong-Tu, Liu Cheng-Hai, Liu Ping
Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Institute of Liver Diseases, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200233, China ; Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China.
Key Laboratory of Liver and Kidney Diseases (Ministry of Education), Institute of Liver Diseases, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200233, China ; E-Institute of Shanghai Municipal Education Commission, Shanghai 201203, China.
Pharmacogn Mag. 2015 Apr-Jun;11(42):417-25. doi: 10.4103/0973-1296.153098.
Yin-Chen-Hao-Tang (YCHT) consists of three aqueous extracts from Artemisia capillaris, Gardenia sp., and prepared Rheum rhabarbarum (rhubarb) (3:2:1). YCHT is characterized by its anti-inflammatory properties in liver regulation and relief of jaundice. We aimed to study the effects and mechanisms of action of YCHT on biliary obstructive cirrhosis.
Secondary biliary fibrosis was induced in rats by bile duct ligation (BDL) and scission. One week after BDL, rats were randomly divided into a saline-treated BDL or YCHT-treated BDL group for 4 weeks. Liver function and hepatic hydroxyproline (Hyp) content were assessed. Types I and IV collagen (Col-IV), laminin, fibronectin, alpha smooth muscle actin (α-SMA), and proliferating cell nuclear antigen protein and messenger ribonucleic acid (mRNA) expression were assessed with immunohistochemistry and real-time polymerase chain reaction.
In the YCHT-treated BDL group, serum total bilirubin, total bile acids, aspartate aminotransferase, alanine aminotransferase, and γ-glutamyl transferase were lower than those in the sham-operated BDL group. The proliferation of bile ducts in hepatic tissues and the Hyp content and Col deposition were also significantly lower than those in control rats. In addition, α-SMA and Col-IV staining was less obvious, and mRNA expression of Procol-α1 (IV), platelet derived growth factor subunit B (PDGF)-B, connective tissue growth factor, and transforming growth factor-beta in proliferative biliary epithelial cells (BECs) in the YCHT-treated BDL group was significantly lower than those in controls.
YCHT effectively reduces the formation of biliary obstructive cirrhosis mainly via inhibition of BEC proliferation by down-regulation of PDGF-B mRNA expression, inhibition of BEC profibrogenic paracrines, and the epithelial-mesenchymal transition pathological process.
茵陈蒿汤由茵陈、栀子和制大黄的三种水提取物组成(3:2:1)。茵陈蒿汤具有肝脏调节和黄疸缓解方面的抗炎特性。我们旨在研究茵陈蒿汤对胆管阻塞性肝硬化的作用及其作用机制。
通过胆管结扎(BDL)和切断在大鼠中诱导继发性胆汁性纤维化。BDL术后1周,将大鼠随机分为生理盐水处理的BDL组或茵陈蒿汤处理的BDL组,持续4周。评估肝功能和肝羟脯氨酸(Hyp)含量。通过免疫组织化学和实时聚合酶链反应评估I型和IV型胶原(Col-IV)、层粘连蛋白、纤连蛋白、α平滑肌肌动蛋白(α-SMA)以及增殖细胞核抗原蛋白和信使核糖核酸(mRNA)表达。
在茵陈蒿汤处理的BDL组中,血清总胆红素、总胆汁酸、天冬氨酸转氨酶、丙氨酸转氨酶和γ-谷氨酰转移酶低于假手术BDL组。肝组织中胆管的增殖以及Hyp含量和胶原沉积也显著低于对照大鼠。此外,α-SMA和Col-IV染色不那么明显,茵陈蒿汤处理的BDL组中增殖性胆管上皮细胞(BECs)中Procol-α1(IV)、血小板衍生生长因子亚基B(PDGF)-B、结缔组织生长因子和转化生长因子-β的mRNA表达显著低于对照组。
茵陈蒿汤主要通过下调PDGF-B mRNA表达抑制BEC增殖、抑制BEC促纤维化旁分泌以及上皮-间质转化病理过程,有效减少胆管阻塞性肝硬化的形成。